656 related articles for article (PubMed ID: 31287555)
1. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract][Full Text] [Related]
2. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract][Full Text] [Related]
3. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
Huang RSP; Harries L; Decker B; Hiemenz MC; Murugesan K; Creeden J; Tolba K; Stabile LP; Ramkissoon SH; Burns TF; Ross JS
Oncologist; 2022 Oct; 27(10):839-848. PubMed ID: 35598205
[TBL] [Abstract][Full Text] [Related]
5. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets.
Gong J; Hu S; Shan Q; Qin J; Han N; Xie F; Lu H
Ther Adv Med Oncol; 2024; 16():17588359241239293. PubMed ID: 38510678
[TBL] [Abstract][Full Text] [Related]
6. Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in ALK and EGFR Driven Non-Small Cell Lung Cancer.
Robin TP; Camidge DR; Stuhr K; Nath SK; Breeze RE; Pacheco JM; Liu AK; Gaspar LE; Purcell WT; Doebele RC; Kavanagh BD; Rusthoven CG
J Thorac Oncol; 2018 May; 13(5):715-720. PubMed ID: 29269007
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
8. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
[TBL] [Abstract][Full Text] [Related]
9. Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS; Patel PR; Curran WJ; Shu HG; Sica GL; Higgins KA
Cancer; 2018 Sep; 124(17):3586-3595. PubMed ID: 30120912
[TBL] [Abstract][Full Text] [Related]
10. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
11. Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring
Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Honda H; Maehara Y
Anticancer Res; 2018 Jun; 38(6):3731-3734. PubMed ID: 29848735
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Suh JH; Johnson A; Albacker L; Wang K; Chmielecki J; Frampton G; Gay L; Elvin JA; Vergilio JA; Ali S; Miller VA; Stephens PJ; Ross JS
Oncologist; 2016 Jun; 21(6):684-91. PubMed ID: 27151654
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
14. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.
Iuchi T; Shingyoji M; Itakura M; Yokoi S; Moriya Y; Tamura H; Yoshida Y; Ashinuma H; Kawasaki K; Hasegawa Y; Sakaida T; Iizasa T
Int J Clin Oncol; 2015 Aug; 20(4):674-9. PubMed ID: 25336382
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profile in Primary Tumor Is Associated with Brain-Tropism of Metastasis from Lung Adenocarcinoma.
Lin YY; Wang YC; Yeh DW; Hung CY; Yeh YC; Ho HL; Mon HC; Chen MY; Wu YC; Chou TY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948172
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases.
Xu Y; Huang Z; Yu X; Chen K; Fan Y
Mol Brain; 2021 Dec; 14(1):176. PubMed ID: 34952628
[TBL] [Abstract][Full Text] [Related]
17. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
18. Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer.
Li H; Zhang X; Cao J; Su P; Lian J; Song X; Yang W; Han S; Xi Y; Wang Y
Tumour Biol; 2015 Dec; 36(12):9251-8. PubMed ID: 26091796
[TBL] [Abstract][Full Text] [Related]
19. Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.
Riess JW; Gandara DR; Frampton GM; Madison R; Peled N; Bufill JA; Dy GK; Ou SI; Stephens PJ; McPherson JD; Lara PN; Burich RA; Ross JS; Miller VA; Ali SM; Mack PC; Schrock AB
J Thorac Oncol; 2018 Oct; 13(10):1560-1568. PubMed ID: 29981927
[TBL] [Abstract][Full Text] [Related]
20. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
